GT
SYRS

Glenmede Trust’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Glenmede Trust’s Portfolio SYRS Stock Details SYRS Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
2017
Q2 		$148K Hold
2017
Q1 		$148K Hold
2016
Q4 		$113K Hold
2016
Q3 		$129K Buy